Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Levine

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
ACS Medicinal Chemistry Letters|September 16, 2014
Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase InhibitorsSharadha Subramanian, Abran Costales, Teresa E Williams, et al.
ACS Medicinal Chemistry Letters|December 18, 2014
Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase InhibitorsSharadha Subramanian, Abran Costales, Teresa E Williams, et al.
Drug and Alcohol Dependence|January 27, 2023
Effect of two counseling interventions on self-reported alcohol consumption, alcohol biomarker phosphatidylethanol (PEth), and viral suppression among persons living with HIV (PWH) with unhealthy alcohol use in Uganda: A randomized controlled trialJudith A Hahn, Robin Fatch, Nneka I Emenyonu, et al.
Journal of Cardiac Failure|February 11, 2005
Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot studyMilton Packer, John McMurray, Barry M Massie, et al.
Journal of Medicinal Chemistry|October 24, 2008
Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitorsSavithri Ramurthy, Sharadha Subramanian, Mina Aikawa, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic MelanomaTeresa E Williams, Sharadha Subramanian, Joelle Verhagen, et al.
Journal of Medicinal Chemistry|November 5, 2014
Design, structure-activity relationship, and in vivo characterization of the development candidate NVP-HSP990Christopher M McBride, Barry Levine, Yi Xia, et al.
Congestive Heart Failure (Greenwich, Conn.)|April 3, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatmentCarl V Leier, Marc A Silver, Michael W Rich, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
ACS Medicinal Chemistry Letters|September 16, 2014
Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase InhibitorsSharadha Subramanian, Abran Costales, Teresa E Williams, et al.
ACS Medicinal Chemistry Letters|December 18, 2014
Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase InhibitorsSharadha Subramanian, Abran Costales, Teresa E Williams, et al.
Drug and Alcohol Dependence|January 27, 2023
Effect of two counseling interventions on self-reported alcohol consumption, alcohol biomarker phosphatidylethanol (PEth), and viral suppression among persons living with HIV (PWH) with unhealthy alcohol use in Uganda: A randomized controlled trialJudith A Hahn, Robin Fatch, Nneka I Emenyonu, et al.
Journal of Cardiac Failure|February 11, 2005
Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot studyMilton Packer, John McMurray, Barry M Massie, et al.
Journal of Medicinal Chemistry|October 24, 2008
Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitorsSavithri Ramurthy, Sharadha Subramanian, Mina Aikawa, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic MelanomaTeresa E Williams, Sharadha Subramanian, Joelle Verhagen, et al.
Journal of Medicinal Chemistry|November 5, 2014
Design, structure-activity relationship, and in vivo characterization of the development candidate NVP-HSP990Christopher M McBride, Barry Levine, Yi Xia, et al.
Congestive Heart Failure (Greenwich, Conn.)|April 3, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatmentCarl V Leier, Marc A Silver, Michael W Rich, et al.
Pageof 7